COARAVEN 300/12.5 MG BOX OF 30

Treatment of essential arterial hypertension. This fixed-dose combination is indicated in adult patients whose blood pressure is inadequately controlled by irbesartan alone or hydrochlorothiazide alone.

Category: Cardio-Metabolic

Description
Reviews (0)

Description

Specialty	COARAVEN
Dosage	12.5 mg, 300 mg
Form	Film-coated tablet
Presentation	B/30
Primary packaging	Blister
Specification	White opaque PVC/PVDC/Alu
INN	HYDROCHLOROTHIAZIDE, IRBESARTAN
VEIC Classification	Essential
Therapeutic Class	CARDIOVASCULAR SYSTEM
Subclass	AGENTS ACTING ON THE RENIN–ANGIOTENSIN SYSTEM
Laboratory	PHILADELPHIA PHARMA
Schedule	A
Shelf life	24 (months)
Generic/Brand	Generic
Marketing Authorization Number	9353044
Marketing Authorization Date	2014-03-14
Range	Cardio-Metabolic Range